University of Ioannina
Συγκριτική μελέτη της σχετιζόμενης με τις μεταγγίσεις θνητότητας των καρδιοχειρουργικών ασθενών και του κόστους των μεταγγίσεων
Abstract
dc:descriptionΒlood transfusion and its related products constitute a vitally important routine practice in cardiac surgery. Hence, it was considered of great importance to explore any correlation between blood transfusion and its products in overall mortality. Another aim of the present study was the assessment of blood cost from pre-transfusion assessment to administration within the context of a cardiac anesthesiology environment which was determined with the intention of prudent blood administration and consequently cost reduction.Materials and Methods: A total of 1183 patients undergoing cardiac surgical procedures throughout 2010-2018 were divided into two groups in 2014, which was a starting point for this study, as structured intraoperative transfusion protocols were initiated that year. In this retrospective and prospective observational study, an association was made between observed mortality and the volume of intraoperative transfusions as well as the applied transfusion practices over eight years.To calculate the cost per transfused blood product unit, both timed data and cost assessment data were utilized for 23 cases of cardiac surgical interventions. Our study was based in a time-driven activity-based costing (TDABC) methodology. Within this framework, specific activities required from pre-transfusion assessment to the completion of blood product administration in the cardiac operating room were identified. The mean time needed for each activity was computed, and the total labor cost was calculated based on the daily wage of the personnel performing each procedure. Subsequently, the cost of consumables required for various procedures was recorded and computed. The total cost for each transfused blood product unit was obtained by summing the personnel cost and the cost of consumable materials used for each distinct procedure.Results: Regarding the comparison of the two patient groups, with the cutoff point being 2014, when structured perioperative transfusion protocols were implemented, a statistically significant difference was found in the mean total number of transfusion products (RBC+FFP+PLT) for patients with structured protocols compared to those without [8.19±0.36 versus 15.55±0.60, p<0.01 (95%CI 6.006-8.717)]. Finally, regarding perioperative mortality between the two subpopulations, 69 deaths were observed among 618 patients (11.16%, with structured protocols) compared to 66 deaths overall in a total of 565 patients (11.68%, without structured protocols), demonstrating non statistically significant difference (p=0.780).The patients of the study were also classified into four groups (PTC) according to perioperative transfusion units (no transfusion, <5, 5-10, >10 units). A key finding of the study was the presence of a dose-dependent relationship between blood transfusion products and mortality. Patients who received >5 units of red blood cells had significantly higher perioperative mortality compared to those who received ≤5. Similarly, patients who received >5 units of FFP had significantly higher perioperative mortality compared to those who received ≤5. Lastly, patients who received ≥10 units of PLT had significantly higher perioperative mortality compared to those who received <10.The cost methodology applied in the study was based on Time-Driven Activity-Based Costing (TDABC). The cost per transfused unit was calculated at €18.35 for erythrocytes, €6.35 for fresh frozen plasma, and €9.26 for platelets, while the consumables cost represented the largest portion of the costing. The total cost was calculated as the sum of labor costs (medical, nursing, auxiliary) and the cost of consumables used for each procedure separately.Conclusions: It was found that in both patient population groups, who underwent cardiac surgeries, there is a direct correlation between mortality and the volume of transfusions. It was also observed that with the implementation of structured protocols, the transfused products were significantly reduced, without directly affecting mortality. In order to determine the total expenditure for each transfused unit, a series of aggregated costs were considered, calculated to form the overall cost of each transfused unit. However, the cost was not easy to determine due to the complex nature of the processes and activities involved in the entire blood transfusion chain.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tzoka, Theodora
- Τζόκα, Θεοδώρα
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/59071